{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T00:25:33Z","timestamp":1759191933228,"version":"3.44.0"},"reference-count":22,"publisher":"Georg Thieme Verlag KG","issue":"20","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Dtsch Med Wochenschr"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1055\/a-2665-9270","type":"journal-article","created":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T22:50:56Z","timestamp":1759186256000},"page":"1216-1225","source":"Crossref","is-referenced-by-count":0,"title":["Langerhanszell-Histiozytose bei Kindern und Erwachsenen \u2013 eine interdisziplin\u00e4re diagnostische und therapeutische Herausforderung"],"prefix":"10.1055","volume":"150","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6022-3439","authenticated-orcid":false,"given":"Thomas","family":"Lehrnbecher","sequence":"first","affiliation":[{"name":"P\u00e4diatrische H\u00e4matologie, Onkologie und H\u00e4mostaseologie, Klinik f\u00fcr Kinder- und Jugendmedizin, Goethe Universit\u00e4t Frankfurt, Deutschland, Frankfurt, GERMANY"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Girschikofsky","sequence":"first","affiliation":[{"name":"I. Interne Abteilung (H\u00e4matologie und Stammzelltransplantation, H\u00e4mostaseologie und medizinischer Onkologie), Ordensklinikum Linz Elisabethinen, \u00d6sterreich, \u00d6sterreich"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anke","family":"Barnbrock","sequence":"additional","affiliation":[{"name":"P\u00e4diatrische H\u00e4matologie, Onkologie und H\u00e4mostaseologie, Klinik f\u00fcr Kinder- und Jugendmedizin, Goethe Universit\u00e4t Frankfurt, Deutschland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luciana","family":"Porto","sequence":"additional","affiliation":[{"name":"Institut f\u00fcr Neuroradiologie, Goethe Universit\u00e4t Frankfurt, Deutschland,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johanna","family":"Schmoll","sequence":"additional","affiliation":[{"name":"Institut f\u00fcr diagnostische und interventionelle Radiologie, Ordensklinikum Linz Elisabethinen, \u00d6sterreich,"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"194","published-online":{"date-parts":[[2025,9,29]]},"reference":[{"key":"ref1","first-page":"342","article-title":"Aktualisierte AWMF-Leitlinie zur Diagnostik und Therapie der Langerhanszell-Histiozytose (LCH) im Kindes- und Jugendalter","volume":"235","author":"T Lehrnbecher","year":"2023","journal-title":"Klin Padiatr"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"2601","DOI":"10.1182\/blood.2021014343","article-title":"International expert consensus recommendations for the diagnosis and treatment of Langerhans cell histiocytosis in adults","volume":"139","author":"G Goyal","year":"2022","journal-title":"Blood"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1056\/NEJMra1607548","article-title":"Langerhans-Cell Histiocytosis","volume":"379","author":"CE Allen","year":"2018","journal-title":"N Engl J Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1275085","article-title":"Langerhans cell histiocytosis: current advances in molecular pathogenesis","volume":"14","author":"T Sconocchia","year":"2023","journal-title":"Front Immunol"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1002\/ajh.26938","article-title":"Molecular and clinicopathologic characterization of pediatric histiocytoses","volume":"98","author":"Z Helias-Rodzewicz","year":"2023","journal-title":"Am J Hematol"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"2416","DOI":"10.1002\/cncr.35301","article-title":"Langerhans cell histiocytosis: NACHO update on progress, chaos, and opportunity on the path to rational cures","volume":"130","author":"K Bielamowicz","year":"2024","journal-title":"Cancer"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1111\/bjh.15577","article-title":"Incidence and risk factors for clinical neurodegenerative Langerhans cell histiocytosis: a longitudinal cohort study","volume":"183","author":"S Heritier","year":"2018","journal-title":"Br J Haematol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0043257","article-title":"Optimal therapy for adults with Langerhans cell histiocytosis bone lesions","volume":"7","author":"MA Cantu","year":"2012","journal-title":"PLoS One"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1182\/blood.2019000934","article-title":"Langerhans cell histiocytosis","volume":"135","author":"C Rodriguez-Galindo","year":"2020","journal-title":"Blood"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"2892","DOI":"10.1111\/apa.16014","article-title":"Clinical features and treatment of Langerhans cell histiocytosis","volume":"110","author":"C Rodriguez-Galindo","year":"2021","journal-title":"Acta Paediatr"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1158\/2159-8290.CD-19-0138","article-title":"Epigenomics and Single-Cell Sequencing Define a Developmental Hierarchy in Langerhans Cell Histiocytosis","volume":"9","author":"F Halbritter","year":"2019","journal-title":"Cancer Discov"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s12890-025-03513-3","article-title":"Pulmonary langerhans cell histiocytosis secondary to Marijuana use: a case report and systematic review of the literature","volume":"25","author":"I Zahid","year":"2025","journal-title":"BMC Pulm Med"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.4084\/MJHID.2016.033","article-title":"Bisphosphonates in Langerhans Cell Histiocytosis: An International Retrospective Case Series","volume":"8","author":"D Chellapandian","year":"2016","journal-title":"Mediterr J Hematol Infect Dis"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1182\/bloodadvances.2016003533","article-title":"Targeted inhibition of the MAPK pathway: emerging salvage option for progressive life-threatening multisystem LCH","volume":"1","author":"A Kolenova","year":"2017","journal-title":"Blood Adv"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"22236","DOI":"10.18632\/oncotarget.25277","article-title":"Vemurafenib in Langerhans cell histiocytosis: report of a pediatric patient and review of the literature","volume":"9","author":"A Heisig","year":"2018","journal-title":"Oncotarget"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"2857","DOI":"10.1200\/JCO.19.00456","article-title":"Vemurafenib for Refractory Multisystem Langerhans Cell Histiocytosis in Children: An International Observational Study","volume":"37","author":"J Donadieu","year":"2019","journal-title":"J Clin Oncol"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1007\/s12185-021-03205-8","article-title":"Vemurafenib provides a rapid and robust clinical response in pediatric Langerhans cell histiocytosis with the BRAF V600E mutation but does not eliminate low-level minimal residual disease per ddPCR using cell-free circulating DNA","volume":"114","author":"D Evseev","year":"2021","journal-title":"Int J Hematol"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1055\/a-2146-1395","article-title":"Therapeutic Strategies In Children And Adolescents With Langerhans Cell Histiocytosis","volume":"235","author":"AE Barnbrock","year":"2023","journal-title":"Klin Padiatr"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1111\/bjh.17243","article-title":"Long-term complications in uniformly treated paediatric Langerhans histiocytosis patients disclosed by 12 years of follow-up of the JLSG-96\/02 studies","volume":"192","author":"K Sakamoto","year":"2021","journal-title":"Br J Haematol"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1002\/cam4.1844","article-title":"Langerhans cell histiocytosis in adults is associated with a high prevalence of hematologic and solid malignancies","volume":"8","author":"J Ma","year":"2019","journal-title":"Cancer Med"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1182\/hematology.2023000439","article-title":"Langerhans cell histiocytosis: promises and caveats of targeted therapies in high-risk and CNS disease","volume":"2023","author":"O Abla","year":"2023","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1093\/brain\/awh403","article-title":"Neuropathology of CNS disease in Langerhans cell histiocytosis","volume":"128","author":"N Grois","year":"2005","journal-title":"Brain"}],"container-title":["DMW - Deutsche Medizinische Wochenschrift"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/a-2665-9270.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T22:51:02Z","timestamp":1759186262000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/a-2665-9270"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,29]]},"references-count":22,"journal-issue":{"issue":"20","published-online":{"date-parts":[[2025,9,29]]},"published-print":{"date-parts":[[2025,10]]}},"URL":"https:\/\/doi.org\/10.1055\/a-2665-9270","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["0012-0472","1439-4413"],"issn-type":[{"value":"0012-0472","type":"print"},{"value":"1439-4413","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,29]]}}}